arrow
M

Masamoto Murakami

University of Miyazaki
H指数:33
被引数:5,194

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial

研究摘要:Apremilast在日本掌跖脓疱病患者中的疗效:一项随机、III期临床试验

2025-12-130
OAAI
Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial

Apremilast在日本掌跖脓疱病患者中的疗效:一项随机、III期临床试验

2025-11-260
OAAI
NIR-II-Excitable Dye-Loaded Nanoemulsions for Two-Photon Microscopy Imaging of Capillary Blood Vessels in the Entire Hippocampal CA1 Region of Living Mice (vol 14, pg 40481, 2022)

NIR-II-可激发染料负载纳米乳液用于活体小鼠海马CA1区域全毛细血管床的双光子显微镜成像(卷14,页40481,2022)

2025-02-120
PRE
Trehalose Prevents IL-4/IL-13–Induced Skin Barrier Impairment by Suppressing IL-33 Expression and Increasing NRF2 Activation in Human Keratinocytes In Vitro

海藻糖通过抑制IL-33的表达和增加NRF2的激活,预防IL-4/IL-13诱导的人角质形成细胞体外皮肤屏障功能障碍

2024-10-090
PRE
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study

阿普斯特治疗日本掌跖脓疱病患者的探索性疗效评估:一项2期、随机、安慰剂对照研究的32周结果

2024-06-190
OAAI
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study (vol 24, pg 837, 2023)

Apremilast治疗日本掌跖脓疱病患者的疗效和安全性: 2期随机,安慰剂对照研究的结果 (第24卷,837页,2023)

2023-12-070
OAAI
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study

司匹索利单抗治疗中重度掌跖脓疱病患者的疗效与安全性:一项多中心、双盲、随机、安慰剂对照、IIb期剂量探索研究

2023-09-2016
OAAI
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study

Apremilast治疗日本掌跖脓疱病患者的疗效和安全性: 一项2期,随机,安慰剂对照研究的结果

2023-05-267
OAAI